Lung regeneration using adipose tissue-derived stem cells~Differentiation into alveolar epithelial cells and development of stem cells therapy~
| Project/Area Number |
18K16417
|
|---|
| Research Category |
Grant-in-Aid for Early-Career Scientists
|
| Allocation Type | Multi-year Fund |
|---|
| Review Section |
Basic Section 55040:Respiratory surgery-related
|
|---|
| Research Institution | Osaka University |
|---|
Principal Investigator |
Fukui Eriko 大阪大学, 医学系研究科, 助教 (90814591)
|
|---|
| Project Period (FY) |
2018-04-01 – 2020-03-31
|
| Project Status |
Completed (Fiscal Year 2019)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 脂肪組織由来幹細胞 / 慢性閉塞性肺疾患 / 細胞移植治療 / 肺胞上皮細胞 / 肺再生 |
|---|
| Outline of Final Research Achievements |
Chronic obstructive pulmonary disease is a leading cause of mortality globally, with no effective therapy yet established. Whether adipose tissue-derived stem cells (ADSCs) differentiate into functional cells remains uncertain, and no study has reported on the mechanism by which ADSCs improve lung functionality. Thus, in this study, we examined whether ADSCs differentiate into lung alveolar cells and are able to ameliorate lung injury caused by elastase-induced emphysema in model mice. Here, we induced ADSCs to differentiate into type 2 alveolar epithelial cells in vitro. We demonstrated that ADSCs can differentiate into type 2 alveolar epithelial cells in an elastase-induced emphysematous lung and that ADSCs improve pulmonary function of emphysema model mice, as determined with spirometry and 129Xe MRI. These data revealed a novel function for ADSCs in promoting repair of the damaged lung by direct differentiation into alveolar epithelial cells.
|
| Academic Significance and Societal Importance of the Research Achievements |
慢性閉塞性肺疾患 (COPD)などの難治性呼吸器疾患は年々著しく増加している。肺移植以外の根治的な治療法は確立されておらず、予後不良であり、新たな治療法の開発が喫緊の課題である。現在の幹細胞治療ではパラクラン効果が主な作用であり、このような非可逆的な肺胞破壊を伴う難治性呼吸器疾患に対しては治療効果に限界がある。本研究では幹細胞自身が肺胞細胞へ分化する可能性を示し、COPDに対する根治的な肺胞再生治療の可能性を示した。
|
Report
(3 results)
Research Products
(4 results)
-
[Journal Article] Adipose Tissue-Derived Stem Cells Have the Ability to Differentiate into Alveolar Epithelial Cells and Ameliorate Lung Injury Caused by Elastase-Induced Emphysema in Mice.2019
Author(s)
Fukui E, Funaki S, Kimura K, Momozane T, Kimura A, Chijimatsu R, Kanzaki R, Kanou T, Ose N, Minami M, Miyagawa S, Sawa Y, Okumura M, Shintani Y.
-
Journal Title
Stem Cells Int.
Volume: 2019
Pages: 5179172-5179172
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
